#2 Bronchiolitis: 2019 RSV Update
Guest: Miguel Knochel, MD, FAAP
February 2019
Show Notes
Disclosures
No commercial support is associated with this CME activity.
Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities
The AAP CME/CPD program develops, maintains, and improves the competence, skills, and professional performance of pediatricians and pediatric healthcare professionals by providing quality, relevant, accessible, and effective educational experiences that address gaps in professional practice. The AAP CME/CPD program strives to meet the educational needs of pediatricians and pediatric healthcare professionals and support their lifelong learning with a goal of improving care for children and families. (AAP CME/CPD Program Mission Statement, May 2015)
The AAP recognizes that there are a variety of financial relationships between individuals and commercial interests that require review to identify possible conflicts of interest in a CME activity. The “AAP Policy on Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities” is designed to ensure quality, objective, balanced, and scientifically rigorous AAP CME activities by identifying and resolving all potential conflicts of interest prior to the confirmation of service of those in a position to influence and/or control CME content. The AAP has taken steps to resolve any potential conflicts of interest.
All AAP CME activities will strictly adhere to the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support: Standards to Ensure the Independence of CME Activities. In accordance with these Standards, the following decisions will be made free of the control of a commercial interest: identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the CME activity.
The purpose of this policy is to ensure all potential conflicts of interest are identified and mechanisms to resolve them prior to the CME activity are implemented in ways that are consistent with the public good. The AAP is committed to providing learners with commercially unbiased CME activities.
DISCLOSURE OF FINANCIAL RELATIONSHIPS
All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content.
* A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Disclosure of Commercial Support for AAP CME Activities
No commercial support is associated with this CME activity.
Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities
The AAP CME/CPD program develops, maintains, and improves the competence, skills, and professional performance of pediatricians and pediatric healthcare professionals by providing quality, relevant, accessible, and effective educational experiences that address gaps in professional practice. The AAP CME/CPD program strives to meet the educational needs of pediatricians and pediatric healthcare professionals and support their lifelong learning with a goal of improving care for children and families. (AAP CME/CPD Program Mission Statement, May 2015)
The AAP recognizes that there are a variety of financial relationships between individuals and commercial interests that require review to identify possible conflicts of interest in a CME activity. The “AAP Policy on Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities” is designed to ensure quality, objective, balanced, and scientifically rigorous AAP CME activities by identifying and resolving all potential conflicts of interest prior to the confirmation of service of those in a position to influence and/or control CME content. The AAP has taken steps to resolve any potential conflicts of interest.
All AAP CME activities will strictly adhere to the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support: Standards to Ensure the Independence of CME Activities. In accordance with these Standards, the following decisions will be made free of the control of a commercial interest: identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the CME activity.
The purpose of this policy is to ensure all potential conflicts of interest are identified and mechanisms to resolve them prior to the CME activity are implemented in ways that are consistent with the public good. The AAP is committed to providing learners with commercially unbiased CME activities.
DISCLOSURE OF FINANCIAL RELATIONSHIPS
All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content.
* A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name | Role |
Relevant Financial Relationship (Please indicate Yes or No) |
Name of Commercial Interest(s)* Please list name(s) of entity AND Nature of Relevant Financial Relationship(s) (Please list: Research Grant, Speaker’s Bureau, Stock/Bonds excluding mutual funds, Consultant, Other – identify) |
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products (Do intend to discuss or Do not intend to discuss) |
Paul Wirkus | Planner/Moderator | NO | NONE | Do not intend to discuss |
Miguel Knochel | Faculty | NO | NONE | Do not intend to discuss |
Carolyn Reynolds | Planner | NO | NONE | Do not intend to discuss |
Alison M. Barrington | Planner | NO | NONE | Do not intend to discuss |
Brooke Hall | Planner | NO | NONE | Do not intend to discuss |
Alisa Stoddard | UTAAP Staff/COI Reviewer-Resolver | NO | NONE | Do not intend to discuss |
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Pediatrics (AAP) and the Utah Chapter of the AAP. The American Academy of Pediatrics is accredited by the ACCME to provide continuing medical education for physicians.
The AAP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is acceptable for a maximum of 1.0 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.
PAs may claim a maximum of 1.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
This program is accredited for 1.0 NAPNAP CE contact hours of which 0 contain pharmacology (Rx) content, (0 related to psychopharmacology) (0 related to controlled substances), per the National Association of Pediatric Nurse Practitioners (NAPNAP) Continuing Education Guidelines.
MOC Statement:
Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 1.0 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
If you do not successfully complete all components of the activity and evaluation assessment ABP MOC Part 2 Points will not be awarded.
Please note: your completion data will be shared with the ABP through the ACCME PARS system within 30 days of successful completion. This will include the name of the activity and provider; participant name; participant’s ABP ID number; participant’s DOB; date of completion of the activity; the PARS activity identifier; ABP MOC Part 2 credit statement and number of MOC points awarded. If any questions or concerns please contact the activity manager alisa@aaputah.org.
Guest: Miguel Knochel, MD, FAAP
Quiz available after 4th episode airs, typically the fourth week of the month.
Virtual Curbside Podcast – Brohcniolitis
Dates valid for credit: November 1, 2019 – October 31, 2022
Claim for Credit
- Learners who complete the activity are eligible for 1.0 AMA PRA Category 1 Credit TM.
- Learners who complete all quiz questions, and who meet the 50% minimum passing score requirements, will be eligible for 1.0 MOC Part 2 points.
Learning Objectives
After listening to these episodes listeners will…
- learn what the recent literature on bronchiolitis shows about hypertonic saline, pulse oximetry, invasive suctioning high-flow nasal cannula.
- discuss treatments and testing options to avoid doing routinely: CXR, viral testing systemic
steriods , inhaled bronchodilators, invasive suctioning (NEW), continuousoximety (NEW). - discuss when to use High Flow Nasal Cannula, what flow rates to provide and when it is not helpful.
Time Stamps Episode 2-1
00:00 Introduction
02:46 Disclosures and Guest Introduction
05:23 RSV
07:22 Suctioning
11:00 How to prevent RSV
13:02 Inpatient management, hypertonic saline, pulse oximetry
17:49 Role of oxygen at home, discontinuation
20:47 Suctioning practices in the hospital
22:36 High Flow Nasal Cannula
23:58 Discharge
24:57 Escalation of care
28:50 Outro
Time Stamps Episode 2-2
00:00 Introduction
03:19 Chest X-ray, AAP recommendation
05:53 Viral testing
08:43 Steroids,
13:09 Choosing Wisely: A Journey
15:10 AAP Change Package: Stewardship in Improving Bronchiolitis
15:45 Office based QI, PDSA cycles
18:34 Outro
Time Stamps Episode 2-3
00:00 Introduction
01:04 High Flow Nasal Cannula
09:27 RSV Vaccine
13:40 Palivizumab
16:33 Outro
Notes Episode 2-4
Dr. Knochel mistakenly mentioned Pediatric Grand Rounds would be March 8th. The correct date is Thursday, March 7th at 8 am. Link below.
Regarding flu swabbing guidelines:
Each lab may differ on acceptable specimens, even given these CDC guidelines. Deep nasal (
For respiratory viral testing, Primary Children’s laboratory does not accept nasal swab + throat swab combo or deep nasal swab (yet), but we do take (with proper labeling & order) the following:
BAL, trach aspirate, Nasopharyngeal wash (in sterile saline), nasopharyngeal swab (UTM or M4 medium), nasopharyngeal aspirate (UTM or M4 medium), sputum sample (older kids who can hack up sputum or expectorate an induced sputum specimen).
Of course, a good question to ask before obtaining respiratory panel testing is: “will this change my management?”
Miguel Knochel MD
Links from the Show
Presenters slides
AAP recommendation
AAP’s Stewardship in Improving Bronchiolitis (SIB) across the continuum of care QI Project
AAP News: Too many missed school days?
AAP News Sick days: Absences can add up quickly
CDC Flu Specimen collection guide
Pediatric Grand Rounds, De-Implementation of Routine Oximetry in Bronchiolitis by Suzanne Schuh, MD, March 7, 2019, 8-9 am. Broadcast available, see link for details.
GermWatch
Acknowledgements
Written and Hosted by: Paul Wirkus, MD, FAAP
Administrator/Producer/Photographer: Alisa Stoddard, UTAAP Executive Director
Audio Engineer: Phil Wirkus
Music by: Phil Wirkus
Guest: Miguel Knochel, MD, FAAP
Special Thanks to Michelle Hofmann, MD, MPH, FAAP, Rob Willer, DO, FAAP and Eric Coon, MD, FAAP